Picture of Orion Oyj logo

ORNBV Orion Oyj News Story

0.000.00%
fi flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Top of the Street: Orion, Nibe, Hiscox

A round-up of notable broker activity this morning from Europe's
top-ranked* analysts:
    
    ** Jefferies downgrades Finnish drug maker Orion  ORNBV.HE 
to "underperform" from "hold" citing over-reliance on the sales
of its cancer drug Nubeqa
    ** Peel Hunt raises Hiscox  HSX.L  to "buy" from "add" on
expected profitable growth and diversification benefits ahead
for the London-listed insurer
    
    INITIATIONS AND REINSTATEMENTS
    ** Citigroup initiates coverage of Swedish heat pump maker
Nibe  NIBEb.ST  with "buy", seeing a potential return to growth
by the end of 2024 as destocking headwinds clear, comparisons
ease into H2
    
(*Analyst rankings from Thomson Reuters StarMine. The scale is
from 1-star to 5-star with 5 being the best. Analysts are ranked
on earnings accuracy as well as relative performance of
recommendations over trailing 12-month & 24-month periods.)


 (Reporting by Elsa Ohlen)

Recent news on Orion Oyj

See all news